Cite
Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.
MLA
Zeng, Qing-Lei, et al. “Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.” Clinical Infectious Diseases, vol. 73, no. 9, Nov. 2021, pp. e3324–32. EBSCOhost, https://doi.org/10.1093/cid/ciaa1939.
APA
Zeng, Q.-L., Yu, Z.-J., Ji, F., Li, G.-M., Zhang, G.-F., Xu, J.-H., Chen, Z.-M., Cui, G.-L., Li, W., Zhang, D.-W., Li, J., Lv, J., Li, Z.-Q., Liang, H.-X., Sun, C.-Y., Pan, Y.-J., Liu, Y.-M., & Wang, F.-S. (2021). Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study. Clinical Infectious Diseases, 73(9), e3324–e3332. https://doi.org/10.1093/cid/ciaa1939
Chicago
Zeng, Qing-Lei, Zu-Jiang Yu, Fanpu Ji, Guang-Ming Li, Guo-Fan Zhang, Jiang-Hai Xu, Zhi-Min Chen, et al. 2021. “Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.” Clinical Infectious Diseases 73 (9): e3324–32. doi:10.1093/cid/ciaa1939.